← Back to Search

Ketorolac in Acute Pancreatitis

Phase 4
Waitlist Available
Led By Anthony J Gentene, PharmD
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during hospital admission
Awards & highlights
All Individual Drugs Already Approved
Approved for 5 Other Conditions
Drug Has Already Been Approved
No Placebo-Only Group
Pivotal Trial

Summary

This trial will compare different ways of managing pain for people hospitalized with acute pancreatitis.

Eligible Conditions
  • Pancreatitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 to day 5 of study
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 to day 5 of study for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Opioids
Secondary study objectives
Morphine
Duration of intravenous opioid use

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 5 Other Conditions
This treatment demonstrated efficacy for 5 other conditions.
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Active Control
Group I: Standard of CareActive Control1 Intervention
Patients receiving standard of care pain management including opioids.
Group II: KetorolacActive Control1 Intervention
Patients will receive standard of care pain management plus intravenous ketorolac.

Find a Location

Who is running the clinical trial?

University of CincinnatiLead Sponsor
439 Previous Clinical Trials
638,688 Total Patients Enrolled
Anthony J Gentene, PharmDPrincipal InvestigatorUniversity of Cincinnati
~10 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top